HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Anthony Selected Research

Tuberculosis (Tuberculoses)

1/2020NTF-RINT, a new method for the epidemiological surveillance of MDR Mycobacterium tuberculosis L2/Beijing strains.
1/2019Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis.
11/2018Can we predict tuberculosis cure? What tools are available?
10/2017IP-10 Kinetics in the First Week of Therapy are Strongly Associated with Bacteriological Confirmation of Tuberculosis Diagnosis in HIV-Infected Patients.
6/2016Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosy.
5/2016Current status and opportunities for therapeutic drug monitoring in the treatment of tuberculosis.
7/2014Optimizing multiplex SNP-based data analysis for genotyping of Mycobacterium tuberculosis isolates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard Anthony Research Topics

Disease

7Tuberculosis (Tuberculoses)
01/2020 - 07/2014
2Peripheral Arterial Disease
12/2006 - 04/2006
1Goiter
05/2024
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2021
1Infections
01/2019
1Extensively Drug-Resistant Tuberculosis
01/2019
1Pulmonary Tuberculosis
11/2018
1Hepatic Encephalopathy
01/2017
1Leprosy (Hansen's Disease)
06/2016
1Extrapulmonary Tuberculosis
10/2015
1Lung Diseases (Lung Disease)
07/2014
1Pain (Aches)
05/2007
1Chronic Limb-Threatening Ischemia
05/2007
1Ischemia
04/2006

Drug/Important Bio-Agent (IBA)

3Rifampin (Rifampicin)FDA LinkGeneric
01/2021 - 06/2016
2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 11/2018
2Biomarkers (Surrogate Marker)IBA
11/2018 - 05/2016
2EcraprostIBA
05/2007 - 04/2006
2Alprostadil (Muse)FDA LinkGeneric
05/2007 - 04/2006
1IodineIBA
05/2024
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2020
1Carbapenems (Carbapenem Antibiotics)IBA
01/2019
1Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
01/2019
1Fetal Proteins (Fetoprotein)IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
07/2014
14- bromo- 6- (3- (4- chlorophenyl)propoxy)- 5- (3- pyridylmethylamino)- 3(2H)- pyridazinone hydrochlorideIBA
12/2006
1Phosphodiesterase InhibitorsIBA
12/2006
1EicosanoidsIBA
04/2006
1ProstaglandinsIBA
04/2006
1ProdrugsIBA
04/2006
1LipidsIBA
04/2006

Therapy/Procedure

3Therapeutics
10/2017 - 04/2006
1Retreatment
10/2015
1Surgical Amputation (Amputations)
05/2007